Conclusion
Population PK models evaluated in this study cannot be used to perform
simulations. A new model must be developed for our population. In
patients positive for P. aeruginosa , Ceftazidime in combination
to tobramycin may be a superior regimen. APE history remains predictive
for outcomes in adult CF patients treated for an APE.